Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
about
Emerging Role of Hypofractionated Radiotherapy with Simultaneous Integrated Boost in Modern Radiotherapy of Breast CancerFrontiers in radiotherapy for early-stage invasive breast cancer.Image-guided radiotherapy for cardiac sparing in patients with left-sided breast cancer.Dosimetric comparison of the simultaneous integrated boost in whole-breast irradiation after breast-conserving surgery: IMRT, IMRT plus an electron boost and VMAT.Comparison of breast simultaneous integrated boost (SIB) radiotherapy techniques.Performance of a Knowledge-Based Model for Optimization of Volumetric Modulated Arc Therapy Plans for Single and Bilateral Breast Irradiation.Comparison of breast sequential and simultaneous integrated boost using the biologically effective dose volume histogram (BEDVH)Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical resultsReduced lung dose during radiotherapy for thoracic esophageal carcinoma: VMAT combined with active breathing control for moderate DIBH.Volumetric modulated arc therapy for treatment of solid tumors: current insights.Dosimetric trade-offs in breast treatment with VMAT technique.Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials.Synchronous bilateral breast cancer irradiation: clinical and dosimetrical issues using volumetric modulated arc therapy and simultaneous integrated boost.Is there a preferred IMRT technique for left-breast irradiation?Application of Volumetric Modulated Arc Therapy and Simultaneous Integrated Boost Techniques to Prepare "Safe Margin" in the Rabbit VX2 Limb Tumor Model.Dosimetric feasibility of an "off-breast isocenter" technique for whole-breast cancer radiotherapyCritical appraisal of the role of volumetric modulated arc therapy in the radiation therapy management of breast cancer.Advantages of a technique using two 50 degree arcs in simultaneous integrated boost radiotherapy for left-sidebreast cancer.A dosimetric comparison of double-arc volumetric arc therapy, step-shoot intensity modulated radiotherapy and 3D-CRT for left-sided breast cancer radiotherapy after breast-conserving surgery.Comorbidities and intensity-modulated radiotherapy with simultaneous integrated boost in elderly breast cancer patients.Treatment of breast cancer with simultaneous integrated boost in hybrid plan technique : Influence of flattening filter-free beams.Hypofractionation with simultaneous integrated boost for early breast cancerRecent Developments in Radiation Oncology: An Overview of Individualised Treatment Strategies in Breast Cancer
P2860
Q26774616-F0E54BCD-38F1-4451-88C5-B2A70C871ECAQ34124291-37A44CF8-140F-46A3-AF19-CBD7E3FA11FBQ34229813-F6C99640-0731-4CD7-BAEA-3964F7ED1829Q35187878-42650373-8D39-405B-818C-D97BC5A7AF68Q35830844-47796DDD-C48F-463D-877C-C92425291710Q35874856-C8C54AFB-38DE-4ACA-A1C6-79B8CE1C9559Q36529659-53F59526-92AB-4680-8D2F-D172DE863AB6Q37263260-D0840DE9-0F79-484C-8647-37565B5D6D0EQ37497033-ECA602B8-C540-4C08-BFF7-B66E4CC6C97AQ38631481-C9D7C5BE-628A-4864-8CA5-CFEF3C86D93AQ38790919-5B90ACFC-76AF-430F-A019-354D26025F15Q38893626-103AD3DA-DB35-4F99-9049-FC535CB20B80Q38948817-5E56F9A5-53D7-4588-B060-054BC6CA2FCAQ40807285-2FBBB143-7ABA-47D4-8D70-4EBFA18F5B2AQ42577447-784C5C21-68B2-4FF5-917B-B9F2957F1B7EQ42592652-376661EA-2D48-4985-9BD1-85AEB2CB4190Q47123354-8F651BDB-1FBA-4A94-8BEE-E586FAA6BB6CQ47160804-C6EB2B14-9854-4604-8AD2-68997A6E24E8Q47590063-6D81A703-8844-475E-B613-EC355C2B8494Q50517201-9353A4DE-E764-4F9E-9A82-1B22E1E9944BQ51540189-4414243E-49D8-40AB-88FF-8A7647A7A068Q57338044-3E2DEC6D-08BA-477D-BAD0-1F4BB72AB159Q57495754-C1DBAC32-531A-41EC-A384-0ABB5A6D258A
P2860
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Phase I-II study of hypofracti ...... ts in the first 50 treatments.
@ast
Phase I-II study of hypofracti ...... ts in the first 50 treatments.
@en
type
label
Phase I-II study of hypofracti ...... ts in the first 50 treatments.
@ast
Phase I-II study of hypofracti ...... ts in the first 50 treatments.
@en
prefLabel
Phase I-II study of hypofracti ...... ts in the first 50 treatments.
@ast
Phase I-II study of hypofracti ...... ts in the first 50 treatments.
@en
P2093
P2860
P50
P356
P1433
P1476
Phase I-II study of hypofracti ...... ts in the first 50 treatments.
@en
P2093
Alberto Testori
Alessandro Clivio
Andrea Sagona
Arianna Rubino
Armando Santoro
Carlo Rossetti
Carlos Garcia-Etienne
Corrado Tinterri
Eugenio Vanetti
Francesca Lobefalo
P2860
P2888
P356
10.1186/1748-717X-7-145
P577
2012-08-28T00:00:00Z
P6179
1017452617